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Abstract
Ebstein’s anomaly is a congenital heart disease that results from failure of delamina-
tion of the tricuspid valve with resulting apical displacement of the septal and posterior 
leaflets of the tricuspid valve. Age at presentation can vary greatly but neonatal presenta-
tion is associated with extraordinary high mortality rates. Comprehensive multispecialty 
care is required starting at the time of fetal diagnosis. Fetal echocardiography is vital 
in monitoring progression of the disease in utero. Fetal echocardiogram can evaluate 
for complications such as arrhythmias, pericardial effusion, or fetal hydrops. Post-natal 
evaluation should include evaluation of functional pulmonary atresia or circular shunt. 
Despite advances in surgical technique for Ebstein’s anomaly, mortality for it remains 
high with early surgical intervention. Aggressive medical management should be used to 
support patients with Ebstein’s anomaly during the neonatal period. Surgical procedures 
for neonatal Ebstein’s vary widely from systemic to pulmonary shunts with or without 
tricuspid valve closure to tricuspid valve repair.
Keywords: neonatal Ebstein’s anomaly, Ebstein’s anomaly, tricuspid valve dysplasia, 
Fetal Ebstein
1. Introduction
Ebstein’s anomaly (EA) was first described by Wilhelm Ebstein in 1866 noting the septal and 
inferior leaflets of the tricuspid valve arose from the right ventricular myocardium [1]. EA is a 
rare congenital heart disease with a prevalence of 2.4 per 10,000 live births [2]. Embryologically, 
EA is a result of varying degrees of failure of leaflets to delaminate from the underlying endo-
cardium that results in a number of characteristic features. There are varying degrees of apical 
displacement of the tricuspid leaflets with the septal leaflet most severely affected followed by 
the posterior leaflet. Furthermore, the right ventricle (RV) is myopathic and is separated into 
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two zones, with an “atrialized” poorly functional portion between the true annulus and the 
hinge point of the apically displaced septal leaflet, while the “functional” RV is the portion 
below the leaflet hinge point. Depending on the degree of leaflet displacement this functional 
RV volume can be quite diminutive.
The clinical manifestations of EA vary widely from mild forms presenting in adulthood, to 
severe forms with high mortality in the neonatal period. In utero, EA can result in hydrops 
and arrhythmia. Furthermore, an in utero diagnosis of EA has an incidence of 48% fetal 
demise [3]. Mortality rates are highest in the neonatal period ranging from 17 to 56% [4] and 
poses significant medical and surgical challenges.
2. Associated anomalies and arrhythmias
Ebstein anomaly is known to have several additional cardiac manifestations. A patent 
foramen ovale or atrial septal defect is normally present. The right to left shunting across 
the defect accounts for the relative hypoxia exhibited in certain patients. RV outflow tract 
obstruction in the form of anatomical pulmonary atresia occurs in about half of the symp-
tomatic neonates requiring surgical intervention [5]. In the setting of pulmonary atresia, a 
patent ductus arteriosus is required as the source of pulmonary blood flow [6–8]. Left ven-
tricular non-compaction cardiomyopathy has been noted to be associated with EA. A retro-
spective study demonstrated that 10 of 61 patients (16%) with EA also had left ventricular 
non-compaction [7]. This was associated with a higher mortality risk of 30% in those with 
LVNC compared to 13% with EA alone. Wolff-Parkinson-White (WPW) is present in about 
10–30% of cases. In about 20% of cases with WPW, there may be more than two accessory 
pathways present. The accessory pathways are usually present on the tricuspid valve annu-
lus [9, 10]. Due to large right atrium, EA patients are at risk for atrial tachycardia, atrial flut-
ter, intra-atrial reentrant tachycardia, atrial fibrillation, AV node reentrant tachycardia, and 
ventricular arrhythmias.
3. Pathologic anatomy
Carpentier et al. described the characteristic features of this disorder that are relevant to surgi-
cal management [11].
1. Failure of delamination of the TV leaflets is the hallmark of EA whereby the leaflets are 
tethered to the endocardium by fibromuscular attachments or abnormal foreshortened 
chordae. Each leaflet exhibits varying degrees of apical displacement and tethering with 
the septal leaflet most severely affected followed by posterior then anterior leaflets. This 
results in anterior and apical displacement of the functional annulus.
2. The anterior leaflet is attached to the true anatomical annulus but is large or sail like.
Congenital Anomalies - From the Embryo to the Neonate150
3. The portion of the RV above the functional annulus (‘atrialized right ventricle’) is dilated 
and thin. The true tricuspid annulus is almost always enlarged. In a neonate this measures 
approximately 21 mm.
4. The cavity of the effective RV is reduced (‘functional right ventricle’).
5. The infundibulum of the RV can be obstructed by the redundant tissue of the anterior leaf-
let and its chordal attachments to the infundibulum.
In addition to the leaflet abnormalities there is a variable degree of ventricular myocardial dysfunc-
tion. Morphometric histopathologic studies have demonstrated that there is an absolute decrease 
in the number of myocardial fibers in addition to thinning of the wall of the dilated RV in EA [12].
Carpentier et al. also described four grades of Ebstein’s anomaly [11].
Type A: The anterior leaflet has normal morphology and the RV is adequate.
Type B: The anterior leaflet has abnormal chordae but normal mobility. The RV is reduced in 
volume but adequate.
Type C: The anterior leaflet is restricted in movement. The RV is small with a large atrialized 
component.
Type D: Also called ‘tricuspide sac’ as the leaflets form a complete sac of fibrous tissue adher-
ent to the RV. The only functional part of the RV is the infundibulum.
3.1. Perinatal period
The long term prognosis of a fetus diagnosed with EA is poor and remains one of the highest 
mortalities amongst congenital heart disease patients. One multicenter study showed that a fetal 
diagnosis of EA resulted in a 17% fetal demise. Furthermore, there was an additional 32% in-hospital 
attrition of live-born babies with EA with an overall 45% perinatal mortality [4]. Risk factors for 
perinatal mortality include lack of antegrade flow across the pulmonary valve, large cardiotho-
racic ratio, earlier in utero diagnosis, large tricuspid valve annulus, pericardial effusion, and right 
ventricular dysfunction [13–16]. Pulmonary valve regurgitation may be the most ominous risk 
factor representing the end result of severe tricuspid regurgitation with resultant volume load on 
a myopathic right ventricle that has to pump against retrograde flow from the PDA. This triad of 
diminished preload, increased afterload and a dysfunctional right ventricle leads to inadequate 
preload to the left ventricle and subsequent heart failure, cardiogenic shock and perinatal demise. 
These factors in-utero lead to hydrops and arrhythmias and ultimately fetal demise.
4. Pathophysiology of the newborn
Neonates are symptomatic as a result of ineffective RV cardiac output and severe TV regurgi-
tation. There is usually some degree of cardiomegaly which can be quite severe compressing 
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the lungs. Furthermore, cyanosis results from systemic venous return being shunted across the 
ASD to the left side of the heart. Neonatal pulmonary vascular resistance (PVR) is elevated and 
this is a major impediment to effective antegrade flow from the diminutive and myopathic 
RV. In the first week of life when pulmonary vascular resistance is high pulmonary blood flow 
is dependent upon the PDA. This results in a physiological state referred to as “functional” 
pulmonary atresia. When the PVR decreases over the first week of life, the RV may then be 
able to overcome the afterload to establish antegrade flow. True anatomical pulmonary atresia 
where there is luminal discontinuity between RV and pulmonary artery is also often seen in 
these symptomatic neonates. These patients will have ductal dependent pulmonary circulation 
until a surgical procedure is performed to establish pulmonary blood flow. Left ventricular 
dysfunction can also play a critical role in the development of decompensated heart failure. This 
is related to left ventricular displacement of the interventricular septum as a result the severely 
dilated dysfunctional RV. This “pancaking” of the LV cavity impedes filling and diminishes 
systemic cardiac output. In less severe forms of EA the RV can generate effective antegrade flow 
especially when the PVR decreases. Antegrade flow across the RV outflow tract is accompanied 
by clinical improvement in symptoms. Neonates with severe TR or gross cardiomegaly who are 
otherwise asymptomatic have an associated mortality of 45% within the first year of life without 
intervention [17, 18]. The natural history of being diagnosed with EA during infancy is sobering 
[19]. However those who survive early childhood can expect reasonable longevity. When the 
disease is mild symptoms are not noticed until later in adult life. Symptoms are often related to 
exercise intolerance or cyanosis from progressive tricuspid regurgitation.
5. Diagnostic evaluation
5.1. Chest X-ray
Depending on the severity of disease, the chest roentgenograms usually demonstrates mas-
sive cardiomegaly with decreased pulmonary vascular markings (Image 1).
5.2. Electrocardiography
The electrocardiograms for patients with EA are usually abnormal. The most common finding 
on ECG are tall P waves and right bundle branch block. The tall P waves are indicative of a 
large right atrium. The right bundle branch block occurs because abnormal development of 
the right bundle branch which appears to be associated with septal leaflet and medial papil-
lary muscle development on necropsy studies [5]. Some patients may have a prolonged PR 
interval from long intra-atrial conduction times from a large right atrium. Wolff-Parkinson-
White syndrome is associated with EA, thus ventricular pre-excitation may be seen on ECG.
5.3. Echocardiography
Echocardiography is the gold standard for obtaining the diagnosis for EA. Two dimensional (2-D) 
echocardiography can evaluate the tricuspid valve leaflets and their excursion. The apical four 
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chamber views allow calculation of the displacement index, which measures the distance from 
the true septal annulus to the level of the apically displaced septal leaflet hinge point (Image 2). 
Distance is indexed to body surface area and values >8 mm/m2 are consistent with EA [20]. Color 
Doppler echocardiography can demonstrate the presence and location of tricuspid valve regurgi-
tation (Image 3) [21]. However, severity can be difficult to quantitate due to apical displacement. 
RV dysfunction and functional or anatomic pulmonary atresia can be evaluated by 2-D and color 
echocardiography [21] Image 4. The Great Ormond Street Echocardiogram (G.O.S.E.) score is a 
mortality risk stratification score for neonates with EA. It is calculated from the apical four chamber 
view by adding the right atrium and atrialized right ventricular volume and dividing by the sum 
of the functional right ventricular volume, left atrial and ventricular volumes. (18) A G.O.S.E score 
of 3 (ratio of 1.1–1.4) with cyanosis or 4 (ratio > 1.5) has a mortality of nearly 100% [18] Image 5.
Echocardiography can define other associated abnormalities with EA such as the presence of 
a patent ductus arteriosus, size and direction of shunting through the atrial septal defect/pat-
ent foramen ovale, presence of a ventricular septal defect, and hypertrabeculated left ventricle 
suggesting left ventricular non-compaction cardiomyopathy.
Fetal echocardiography is a useful diagnostic tool for prenatal diagnosis and monitoring pro-
gression of disease in utero. The 4-chamber view of the fetal heart will demonstrate apical dis-
placement of the tricuspid valve annulus, enlarged right ventricular and atrial size, and large 
tricuspid valve annulus (Image 6). Color flow imaging can be used to evaluate the degree 
of tricuspid valve regurgitation. The pulmonary valve can be evaluated by 2-D and color 
flow imaging to assess for pulmonary atresia. M-mode assessment can determine any rhythm 
abnormalities such as supraventricular tachycardia [22]. In addition, signs of hydrops such as 
pericardial effusions can be visualized (Image 7).
Fetal echocardiogram is important for monitoring clinical status of the fetus during pregnancy. 
A large multicenter study performed by Freud et al. evaluated over 400 fetal echocardiograms 
of patients with EA. They demonstrated that larger cardiothoracic ratio, more than  moderate 
Image 1. Chest x-ray of an infant with EA. there is marked cardiomegaly with a significant cardiothoracic ratio. With 
marked cardiomegaly lung development can be impaired.
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 tricuspid regurgitation, larger tricuspid annulus diameter z-score, larger diameter vena con-
tracta for tricuspid regurgitation, lack of antegrade pulmonary blood flow, pulmonary regur-
gitation, and pericardial effusion were associated with increased perinatal mortality [4]. 
Furthermore, Tierney et al. demonstrated that only 31% of fetuses had no predictive risk fac-
tors for poor hemodynamic status at time of diagnosis, and of those, 61% went on to develop 
one or more signs later in gestation. As such, frequent fetal echocardiograms are necessary to 
monitor the clinical status of fetuses with EA [23].
5.4. Computed tomography/magnetic resonance imaging
There is limited utility for the use of CT, MRI, or cardiac catheterization in neonatal EA.
5.5. Treatment
5.5.1. Medical
In a study of 415 neonates presenting with symptomatic EA the overall hospital mortality 
was 24% [19]. Furthermore, surgical intervention in the neonatal period across US hospitals is 
Image 2. Apical 4 chamber view of Ebstein’s anomaly with severe enlargement of the right atrium and atrialized portion 
of the right ventricle. There is apical displacement of the tricuspid valve with tethering of the septal leaflet leading to 
poor coaptation and tricuspid valve regurgitation. RA: Right atrium. LA: Left atrium. aRV: Atrialized right ventricle. LV: 
Left ventricle. fRV: Function right ventricle.
Congenital Anomalies - From the Embryo to the Neonate154
Image 3. Apical 4 chamber with color flow imaging of the tricuspid valve. There is severe tricuspid valve regurgitation 
due to poor coaptation of the tricuspid valve leaflets.
Image 4. Color compare parasternal short axis view demonstrates the small functional right ventricle and pulmonary 
atresia. The tricuspid valve is rotated in a fashion that the effective orifice opens to the right ventricular outflow tract. 
Color Doppler demonstrates swirling of blood in the functional right ventricle, tricuspid regurgitation, and no antegrade 
pulmonary blood flow. aRV: Atrialized right ventricle.
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associated with a mortality of 27–36% depending on the procedure performed [19]. There is 
significant improvement in surgical outcome if the patient can be medically managed out of 
the neonatal period [24]. As such the best survival rates for EA occurs outside of the neonatal 
period, thus medical management with supportive care is crucial for improving outcomes.
Image 6. Fetal echocardiogram performed at 22 weeks and 3 days gestation. There is severe enlargement of the right 
atrium with severe tricuspid valve regurgitation demonstrated on color Doppler evaluation. The tricuspid valve annulus 
dimension is markedly enlarged.
Image 5. Apical four chamber view demonstrating the right atrium, atrialized portion of the right ventricle, functional 
right ventricle, left atrium and left ventricle. There is a grade 3 GOSE score which correlates with 100% mortality in 
presence of cyanosis. RA = right atrium. aRV = atrialized right ventricle. fRV = functional right ventricle. LA = left atrium. 
LV = left ventricle.
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Relatively stable but symptomatic patients can be treated with prostaglandin infusion to main-
tain ductal patency if functional or anatomical pulmonary atresia is evident. Supplemental 
oxygen should not be greater than 21% fractional inspired oxygen to avoid pulmonary over-
circulation and volume loading of the heart. During this phase oxygen saturation should be 
maintained between 75 and 85%. As the pulmonary vascular resistance decreases, prosta-
glandin therapy can be discontinued. This will also allow for proper evaluation of antegrade 
pulmonary blood flow as the ductus closes. If saturations decrease under 80% then agents to 
lower pulmonary vascular resistance can be administered to promote antegrade flow, these 
include supplemental oxygen and nitric oxide.
Use of prostaglandins in the presence of pulmonary valve regurgitation may exacerbate heart 
failure symptoms due to the development of a circular shunt. In this physiology blood flows 
from left ventricle to aorta, then it is shunted away from the systemic circulation via the large 
ductus to the pulmonary artery then retrograde via the pulmonary valve into the right ven-
tricle to right atrium via the incompetent tricuspid valve then back to the left side of the heart 
via the ASD. This creates high output heart failure. Prostaglandins should be stopped if this 
physiology exists.
Further hemodynamic instability leads to cardiogenic shock. In these situations intubation 
and mechanical ventilation with large tidal volumes are key to promoting adequate ventila-
tion in patients with massive cardiomegaly. Furthermore, sedation and possible paralysis 
to limit oxygen requirements may be required. Inotropic support in the form of milrinone 
complemented with low dose of dopamine or epinephrine may be necessary to assist with 
cardiac output. Tachyarrhythmias are common in this group of patients so utilization of cat-
echolamine inotropes should be used sparingly.
Image 7. Fetal echocardiogram at 22 weeks and 3 days gestation with a four chamber view of the heart. The heart 
mass takes up the entire thoracic cavity. There is severe enlargement of the right atrium with evidence of a pericardial 
effusion. RA: Right atrium. RV: Right ventricle. LA: Left atrium. LV: Left ventricle.
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Milrinone is a very effective drug since it has lusitropic and inotropic effects on the right 
ventricle. Furthermore, it decreases the pulmonary vascular resistance which promotes 
antegrade pulmonary blood flow. Frequent echocardiograms during the first week are 
useful to assess antegrade flow across the RV outflow tract and degree of TV regurgi-
tation. This assessment will help guide weaning prostaglandins, and initiation of nitric 
oxide and inotropes.
In summary, medical management when pulmonary ductal dependency exists is analogous to 
single ventricle physiology whereby a balance between systemic and pulmonary circulation 
needs to be established. This is best done with maintenance of prostaglandins and low oxy-
gen supplementation. Once the pulmonary vascular resistance drops and there is antegrade 
flow across the pulmonary valve then this management is more analogous to two ventricle 
physiology with a poor right ventricular pump. As such this is best managed by stopping 
prostaglandins and allowing for ductal closure. Concomitantly administration of nitric oxide, 
milrinone and higher oxygen supplementation will augment antegrade flow.
The goal of medical therapy is to avoid an operation particularly during the neonatal period 
when mortality is highest for any surgical procedure performed.
5.6. Surgical indications
Surgical indications for EA include failure to wean from mechanical ventilator support, fail-
ure to wean off prostaglandin with systemic oxygen saturation below 75%, functional or ana-
tomic pulmonary atresia, Great Ormond Street Echocardiography (G.O.S.E.) score of 3 or 4, 
and patients with right heart failure.
5.7. Surgical procedures
To date there has been many procedures described for the surgical treatment for neonatal EA 
[11, 25–28, 31–35].
Danielson at the Mayo Clinic first described some of the essential principles for EA repair in 
any age group [25]. This includes plication of the atrialized RV, posterior tricuspid annulo-
plasty, closure of ASD and right reduction atrioplasty.
The cone reconstruction first described by da Silva and colleagues has now evolved into the 
technique of choice when repairing the tricuspid valve for EA [27]. In this procedure, the ante-
rior and posterior leaflets of the tricuspid valve are mobilized from their attachments to the 
RV endocardium maintaining free edge attachments. The mobilized leaflets are rotated clock-
wise and then reattached to the true annulus [36]. To date there has been a growing number 
of reports of utilization of the Cone procedure for neonatal EA [27].
Starnes et al. reported a single ventricle palliation strategy for neonates with good outcome 
[29]. In the Starnes procedure the RV is excluded by performing a fenestrated patch closure 
of the tricuspid valve. An atrial septectomy allows for excellent mixing. Finally, a modified 
Blalock-Taussig-Thomas shunt is performed to establish a regulated source of pulmonary 
blood flow. Most neonates undergoing a Starnes RV exclusion procedure are then channeled 
down a single ventricle pathway with a bidirectional Glenn and Fontan procedures.
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The two competing strategies for surgical treatment for neonatal EA are whether to perform a 
biventricular repair or a single ventricle palliative procedure (Starnes Procedure).
The decision for which type of repair is best for neonatal EA is controversial. Mizuno et al. 
described their center experience with neonatal EA repair. Their results demonstrated greater 
survival for the biventricular repair group compared to single ventricle palliation, 60 vs. 25% 
respectively [30]. A recent follow up study by Kumar et al. evaluated the median 7 year fol-
low up for the Starnes procedure in 27 neonatal repairs [29]. Their overall survival for 5 year 
follow up was 81%. Boston et al. described their outcomes for neonatal biventricular repair 
for EA. Early survival was 78.1% in their series, while 15 year survival for EA with and with-
out anatomical pulmonary atresia was 40 and 79% respectively. As such caution should be 
advised for biventricular repairs in EA neonates with anatomical pulmonary atresia [25, 36].
In summary, neonatal EA continues to carry a high perinatal mortality upon fetal diagno-
sis. A multidisciplinary approach is required for improved outcomes. Fetal echocardiog-
raphy predicts outcome and is necessary for monitoring progression of EA complications. 
Comprehensive care with a multi-disciplinary team including high risk obstetrician, pediatric 
cardiologist, pediatric cardiothoracic surgeon, neonatal intensivist should occur at a tertiary 
care center. Surgical management during the neonatal period remains high. If possible medi-
cal management through the neonatal period improves mortality.
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